Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 457

    1.

    Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.

    Sethi AA, Tybjaerg-Hansen A, Grønholdt ML, Steffensen R, Schnohr P, Nordestgaard BG.

    Ann Intern Med. 2001 May 15;134(10):941-54.PMID: 11352695 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease.

    Sethi AA, Nordestgaard BG, Grønholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A.

    Hypertension. 2003 Jun;41(6):1202-11. Epub 2003 May 12.PMID: 12743009 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia]

    Sethi AA, Tybjaerg-Hansen A, Grønhold ML, Steffensen R, Schnohr P, Nordestgaard BG.

    Lakartidningen. 2002 May 23;99(21):2392-3. Swedish. No abstract available. PMID: 12090166 [PubMed - indexed for MEDLINE]Related articles

    4.

    ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease.

    Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R, Grønholdt ML, Jensen G, Nordestgaard BG.

    Ann Intern Med. 1997 Sep 1;127(5):346-55.PMID: 9273825 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.

    Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG; Copenhagen City Heart Study.

    J Am Coll Cardiol. 2003 Aug 20;42(4):661-7.PMID: 12932598 [PubMed - indexed for MEDLINE]Related articles

    6.

    Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.

    Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, Steffensen R, Nordestgaard BG.

    Circulation. 2000 Oct 31;102(18):2197-203.PMID: 11056092 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.

    Wittrup HH, Andersen RV, Tybjaerg-Hansen A, Jensen GB, Nordestgaard BG.

    J Clin Endocrinol Metab. 2006 Apr;91(4):1438-45. Epub 2006 Jan 17.PMID: 16418216 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.

    Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, Jensen G, Nordestgaard BG.

    Circulation. 2004 Jan 6;109(1):59-65. Epub 2003 Dec 8.PMID: 14662715 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.

    Stene MC, Frikke-Schmidt R, Nordestgaard BG, Steffensen R, Schnohr P, Tybjaerg-Hansen A.

    Atherosclerosis. 2006 Sep;188(1):43-50. Epub 2005 Nov 14.PMID: 16289551 [PubMed - indexed for MEDLINE]Related articles

    10.

    Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease.

    Olivieri O, Stranieri C, Girelli D, Pizzolo F, Grazioli S, Russo C, Pignatti PF, Corrocher R.

    J Hypertens. 2001 May;19(5):879-84.PMID: 11393670 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

    Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG.

    J Am Coll Cardiol. 2003 Jun 4;41(11):1972-82.PMID: 12798568 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

    Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A.

    JAMA. 2008 Jun 4;299(21):2524-32.PMID: 18523221 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population.

    Frikke-Schmidt R, Nordestgaard BG, Schnohr P, Steffensen R, Tybjaerg-Hansen A.

    J Am Coll Cardiol. 2005 Oct 18;46(8):1516-20. Epub 2005 Sep 23.PMID: 16226177 [PubMed - indexed for MEDLINE]Related articles

    14.

    Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.

    Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG.

    Blood. 2002 Jul 1;100(1):3-10.PMID: 12070000 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis.

    Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A.

    Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1269-75. Epub 2003 Jun 12.PMID: 12805070 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population.

    Frossard PM, Hill SH, Elshahat YI, Obineche EN, Bokhari AM, Lestringant GG, John A, Abdulle AM.

    Clin Genet. 1998 Oct;54(4):285-93.PMID: 9831339 [PubMed - indexed for MEDLINE]Related articles

    17.

    ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study.

    Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sørensen TI, Jensen G, Tybjaerg-Hansen A.

    Circulation. 1997 May 20;95(10):2358-67.PMID: 9170397 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.

    Ravn LS, Benn M, Nordestgaard BG, Sethi AA, Agerholm-Larsen B, Jensen GB, Tybjaerg-Hansen A.

    Pharmacogenet Genomics. 2008 Jun;18(6):525-33.PMID: 18496132 [PubMed - indexed for MEDLINE]Related articles

    19.

    A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

    Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH.

    N Engl J Med. 1995 Mar 16;332(11):706-11.PMID: 7854377 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study.

    Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A.

    Atherosclerosis. 2002 Nov;165(1):119-26.PMID: 12208477 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data